etoposide has been researched along with Lymphoma, T Cell, Peripheral in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.45) | 18.2507 |
| 2000's | 21 (30.43) | 29.6817 |
| 2010's | 31 (44.93) | 24.3611 |
| 2020's | 16 (23.19) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Feng, X; Gao, Y; Li, H; Li, Z; Shi, C; Song, W; Zhang, M | 1 |
| Cai, Q; Song, W; Sun, X; Wang, L; Wang, Y; Xue, H; Zhang, H; Zhang, L; Zhang, M; Zou, L | 1 |
| Gentille, C; Joshi, J; Pingali, SR; Randhawa, J; Sarfraz, H; Shah, S | 1 |
| Böhmer, LH; Brink, M; Huls, GA; Jansen, PM; Kersten, MJ; Meeuwes, FO; Mutsaers, PGNJ; Nijland, M; Oostvogels, R; Plattel, W; van der Poel, MWM; Vermaat, JSP; Visser, O; Woei-A-Jin, FJSH; Wondergem, M | 1 |
| Bai, B; Cai, Q; Gao, Y; He, H; He, Y; Huang, C; Huang, H; Huang, Y; Li, Z; Liu, Y; Pan, X; Ping, L; Wang, X; Zeng, W | 1 |
| Barreto, GC; Brito, CV; Costa, RO; Culler, HF; Lage, LAPC; Levy, D; Pereira, J; Reichert, CO; Rocha, V; Zerbini, MCN | 1 |
| Chen, JB; Liu, L; Tang, XQ; Wang, J; Wang, L; Wang, X; Xiong, YY; Zhang, HB | 1 |
| Vose, JM | 1 |
| Chen, Y; Qu, H; Shan, N; Xu, H | 1 |
| Wang, W; Wei, C; Zhang, W; Zhang, Y; Zhao, D; Zhou, D | 1 |
| Camou, F; Gabriel, F; Issa, N; Larroquette, M | 1 |
| Anticoli Borza, P; Banchi, M; Battistini, R; Bocci, G; Cox, MC; Di Gregorio, F; Di Napoli, A; Marcheselli, L; Orlandi, P; Patti, C; Pelliccia, S | 1 |
| Aoudjhane, M; Cervera, P; Coppo, P; Corre, E; Duléry, R; Fabiani, B; Lemonnier, MP; Marjanovic, Z; Mohty, M; Van de Wyngaert, Z | 1 |
| Altmann, B; Banos, A; Bay, JO; Bilger, K; Bouabdallah, K; Braulke, F; Cartron, G; Damaj, G; de Leval, L; Delmer, A; Dreger, P; Dreyling, M; Friedrichs, B; Gaulard, P; Gisselbrecht, C; Glass, B; Gyan, E; Haenel, M; Jaccard, A; Keller, U; Kroschinsky, F; Lamy, T; Leclerc, M; Lindemann, W; Metzner, B; Milpied, N; Nickelsen, M; Poeschel, V; Reimer, P; Rosenwald, A; Roussel, M; Sanhes, L; Schmitz, N; Sibon, D; Tournilhac, O; Truemper, L; Viardot, A; Wagner, E; Wilhelm, M; Wulf, G; Ziepert, M | 1 |
| Audino, AN; Saraf, A; Wedekind, MF; Willen, F | 1 |
| Guo, L; Hu, X; Li, S; Liang, X; Wen, S | 1 |
| Gomyo, H; Hiramatsu, Y; Maeda, Y; Masaki, Y; Masunari, T; Matsuo, K; Nakamura, S; Nawa, Y; Nishimori, H; Ohshima, K; Sunami, K; Takahashi, T; Tanimoto, M; Uno, M; Yamane, H; Yano, T; Yoshida, I; Yoshino, T | 1 |
| Jaffe, ES; Lucas, A; Melani, C; Pittaluga, S; Roschewski, M; Roswarski, J; Steinberg, SM; Waldmann, TA; Wilson, WH | 1 |
| Chihara, D; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Garg, N; Horowitz, SB; Hosing, C; Kamble, RT; Khouri, IF; Nastoupil, L; Nieto, Y; Oki, Y; Romaguera, JE; Ruben, CE; Samaniego, F; Stafford, MD; Strati, P; Wesson, ET | 1 |
| Liu, W; Liu, X; Song, Y; Wu, M; Xie, Y; Yang, M; Zheng, W; Zhu, J | 1 |
| Belada, D; Bortlicek, Z; Campr, V; Chloupkova, R; Duras, J; Hamouzova, J; Janikova, A; Klener, P; Kopalova, N; Mayer, J; Mocikova, H; Pirnos, J; Prochazka, V; Pytlik, R; Trneny, M | 1 |
| Boguradzki, P; Czyz, A; Dytfeld, D; Hawrylecka, D; Helbig, G; Hellmann, A; Knopinska-Posluszny, W; Komarnicki, M; Kopinska, A; Kyrcz-Krzemien, S; Lojko-Dankowska, A; Nasilowska-Adamska, B; Piatkowska-Jakubas, B; Poplawska, L; Romejko-Jarosinska, J; Walewski, J | 1 |
| Berdel, WE; Demant, A; Evers, G; Kessler, T; Köhler, G; Krug, U; Kuhlmann, M; Mesters, R; Mikesch, JH; Mohr, M; Müller-Tidow, C; Pohlen, M; Schliemann, C; Schmidt, E; Thoennissen, GB; Thoennissen, NH; Wessling, J | 1 |
| Bachour, M; Hussein, T; Kenj, M; Salamoon, M | 1 |
| Horwitz, S; Lunning, MA; Moskowitz, AJ | 1 |
| Chai-Adisaksopha, C; Nawarawong, W; Norasetthada, L; Rattarittamrong, E; Tantiworawit, A | 1 |
| Ellin, F; Jerkeman, M; Landström, J; Relander, T | 2 |
| Ichikawa, M; Kogure, Y; Kurokawa, M; Nakamura, F; Nannya, Y; Ueda, K; Yoshimi, A | 1 |
| Liu, Z; Medeiros, LJ; Young, KH | 1 |
| Kheradpour, A; Rowsell, EH; Wang, J; Weiss, LM; Zhang, H; Zuppan, CW | 1 |
| Beaven, AW; Diehl, LF | 1 |
| Dong, M; Gui, L; He, X; Hu, S; Jia, B; Lin, H; Liu, P; Qin, Y; Shi, Y; Sun, Y; Wang, L; Xing, P; Yang, J; Yang, S; Zhang, C; Zhou, L; Zhou, S | 1 |
| Ishida, T; Ogura, M; Takahashi, T; Tsukasaki, K; Utsunomiya, A | 1 |
| Agostinelli, C; Grandi, V; Patrizi, A; Pellegrini, C; Pileri, A; Pimpinelli, N; Zinzani, PL | 1 |
| Chen, JY; Lu, C; Tang, X; Wang, JW | 1 |
| Gutierrez, A; Rodriguez, J | 1 |
| Xie, Y; Zheng, W; Zhu, J | 1 |
| Angamuthu, N; Boyd, K; Chasty, R; Davies, J; Forsyth, P; Jack, F; Lennard, AL; Lyons, S; Mounter, P; Proctor, SJ; Revell, P; Sieniawski, M | 1 |
| Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Eghbali, H; Foussard, C; Gressin, R; Jaubert, J; Lamy, T; le Gouill, S; Lucas, V; Maloisel, F; Milpied, N; Peoch, M; Rossi, JF; Simon, A; Thyss, A; Tournilhac, O; Vilque, JP | 1 |
| Cai, JL; Delioukina, M; Forman, SJ; Gaal, K; Kogut, N; Nademanee, A; Palmer, JM; Popplewell, L; Tsai, NC | 1 |
| Hayama, M; Nakamine, H; Nakamura, S; Niitsu, N; Okamoto, M; Tamaru, J; Yoshino, T | 1 |
| Delioukina, M; Forman, SJ; Gaal, K; Kogut, N; Nademanee, A; O'Donnell, M; Palmer, JM; Popplewell, L; Senitzer, D; Thomas, S; Tsai, NC; Zain, J | 1 |
| Fisher, RI; LeBlanc, M; Mahadevan, D; Miller, TP; Persky, DO; Spier, CM; Unger, JM; Young, F | 1 |
| Anderson, H; Brown, P; d'Amore, F; Delabie, J; Erlanson, M; Fagerli, UM; Gadeberg, OV; Hagberg, H; Holte, H; Jantunen, E; Kuittinen, O; Lauritzsen, GF; Merup, M; Österborg, A; Ralfkiaer, E; Relander, T; Sundström, C; Toldbod, HE; Vornanen, M; Østenstad, B | 1 |
| al-Farsi, K; Crump, M; Keating, A; Kuruvilla, J; Puig, N; Seshadri, T; Wang, L | 1 |
| Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
| Ahn, JS; Chae, YS; Jung, SH; Kim, HJ; Kim, YK; Kwak, JY; Lee, JJ; Lee, SR; Sohn, SK; Yang, DH; Yhim, HY | 1 |
| Hagiwara, S; Iyama, S; Kato, J; Kobayashi, D; Kogawa, K; Kuribayashi, K; Matsunaga, T; Niitsu, Y; Oku, T; Sato, T; Sato, Y; Takada, K; Takahashi, M; Takahashi, S; Terui, T | 1 |
| Crump, M; Keating, A; Mollee, P; Song, KW | 1 |
| Arranz, R; Caballero, MD; Carreras, E; Conde, E; Fernández de Sevilla, A; Gandarillas, M; García-Laraña, J; Gutiérrez, A; Lahuerta, JJ; León, A; Marín, J; Rifon, J; Rodríguez, J; SanMiguel, J; Sureda, A; Varela, R; Zuazu, J | 1 |
| Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, XB; Pan, ZH; Peng, YL; Wang, W; Xia, ZJ | 1 |
| Alaibac, M; Aversa, S; Berti, E; Chiarion, V; Marino, F; Peserico, A; Pigozzi, B | 1 |
| Hakamada, A; Isoda, K; Mizutani, H; Nomura, E; Yamaguchi, M; Yamanaka, K | 1 |
| Choi, HY; Jeon, YK; Kim, CW; Kim, H; Kim, JE; Kim, YA; Kim, YN; Park, SO; Park, SS | 1 |
| Baek, JH; Chae, YS; Chung, IJ; Joo, YD; Kim, DH; Kim, HJ; Kim, JG; Lee, JJ; Lee, KB; Lee, WS; Sohn, CH; Sohn, SK; Yang, DH | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M | 1 |
| Haas, A; Hummel, M; Lobeck, H; Maschmeyer, G | 1 |
| Bishton, MJ; Haynes, AP | 1 |
| Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lu, TX; Xia, YF; Xian, CG; Zhang, YJ | 1 |
| Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM | 1 |
| Alvés, J; Benitez, J; Carnero, A; Cigudosa, JC; Cuadros, M; Leskelä, S; Martín, C; Martínez-Delgado, B; Moneo, MV; Robledo, M; Rodríguez-Antona, C; Zajac, M | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Avilés, A; Castañeda, C; Cleto, S; González, M; Huerta-Guzmán, J; Nambo, MJ; Neri, N; Talavera, A | 1 |
| Briones, J; Camós, M; Colomo, L; Escoda, L; Espinosa, I; Estany, C; Gutiérrez-García, G; López-Guillermo, A; Martínez, S; Martino, R; Mercadal, S; Montserrat, E; Pedro, C; Ribera, JM; Xicoy, B | 1 |
| Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M | 1 |
| Ammatuna, E; Barbera, V; Florena, AM; Franco, V; Gerlando, Q; Mariani, G | 1 |
2 review(s) available for etoposide and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pegylated liposomal doxorubicin (PLD)-containing regimen as a novel treatment of monomorphic epithelial intestinal T-cell lymphoma (MEITL): A case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Enteropathy-Associated T-Cell Lymphoma; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Prednisone; Vincristine | 2022 |
Durable Response in Relapsed Adolescent Peripheral T-cell Lymphoma: A Case Report and Review of the Literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Recurrence; Stem Cell Transplantation | 2022 |
17 trial(s) available for etoposide and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia; Prednisone; Thalidomide; Treatment Outcome | 2022 |
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Topics: Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Myeloablative Agonists; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prospective Studies; Risk; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2021 |
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707.
Topics: Adult; Age Factors; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Neutropenia; Prednisone; Thrombocytopenia; Treatment Outcome; Vincristine | 2017 |
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2018 |
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Recurrence; Retreatment; Treatment Outcome | 2018 |
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Vincristine | 2014 |
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2010 |
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Prospective Studies; Survival Rate; Transplantation, Autologous; Whole-Body Irradiation | 2011 |
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Doxorubicin; Epidemiologic Methods; Etoposide; Female; Hematologic Diseases; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Prednisolone; Prognosis; Treatment Outcome; Vincristine; Young Adult | 2011 |
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Treatment Outcome; Young Adult | 2013 |
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prednisone; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2012 |
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 2006 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine; Young Adult | 2008 |
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2008 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1994 |
50 other study(ies) available for etoposide and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma.
Topics: Aminopyridines; Benzamides; Cell Line, Tumor; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Lymphoma, T-Cell, Peripheral | 2023 |
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Depsipeptides; Etoposide; Humans; Ifosfamide; Ki-1 Antigen; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Receptor Protein-Tyrosine Kinases; Testicular Neoplasms; Transplantation, Autologous; Vincristine | 2022 |
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Topics: Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Retrospective Studies | 2023 |
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 2022 |
Comparison of CEAC, BEAM and IEAC conditioning regimens followed by autologous stem cell transplantation in peripheral T-cell lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2022 |
To transplant or not to transplant: that is the question in PTCL.
Topics: Cohort Studies; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Transplantation, Autologous | 2022 |
Long-time follow-up of patients with untreated peripheral T cell lymphoma following chidamide combined with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide therapy: a single-center propensity score-matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Propensity Score; Retrospective Studies; Vincristine; Vindesine | 2023 |
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brown-Sequard Syndrome; Cyclophosphamide; DNA, Fungal; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Neuroaspergillosis; Opportunistic Infections; Prednisolone; Quadriplegia; Vincristine | 2020 |
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
Topics: Administration, Metronomic; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Organic Chemicals; Prednisone; Progression-Free Survival; Prospective Studies; Vinorelbine | 2020 |
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2021 |
Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Prognosis; Progression-Free Survival; Regression Analysis; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2021 |
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Progression-Free Survival; Retrospective Studies; Thrombocytopenia; Vincristine; Young Adult | 2019 |
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Autologous; Vincristine | 2019 |
Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2013 |
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Mucositis; Peripheral Blood Stem Cell Transplantation; Preoperative Care; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Depsipeptides; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Humans; Induction Chemotherapy; Lymphoma, T-Cell, Peripheral; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Prednisone; Recurrence; Severity of Illness Index; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Vincristine | 2013 |
CHOEP-21 chemotherapy for newly diagnosed nodal peripheral T-cell lymphomas (PTCLs) in Maharaj Nakorn Chiang Mai Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prospective Studies; Thailand; Treatment Outcome; Vincristine; Young Adult | 2013 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Registries; Survival Analysis; Sweden; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2014 |
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies | 2015 |
Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
Topics: Adult; Alcoholism; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Gene Rearrangement; Humans; Immunohistochemistry; Lymphoma, T-Cell, Peripheral; Male; Muscle, Skeletal; Prednisone; Receptors, Antigen, T-Cell, gamma-delta; Rhabdomyolysis; Tomography, X-Ray Computed; Vincristine | 2017 |
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Recurrence; Registries; Sweden; Vincristine | 2015 |
Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Topics: Age of Onset; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Granzymes; Herpesvirus 4, Human; Humans; Infant; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Male; Otitis; Perforin; Poly(A)-Binding Proteins; Prednisolone; Remission Induction; T-Cell Intracellular Antigen-1; T-Lymphocytes, Cytotoxic; Vincristine | 2015 |
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Approval; Etoposide; Europe; Humans; International Cooperation; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Medical Oncology; Neoplasm Recurrence, Local; Oligopeptides; Prednisolone; Prognosis; Recurrence; Remission Induction; Risk; Treatment Outcome; United States; United States Food and Drug Administration; Vincristine | 2015 |
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Vincristine | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 2016 |
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermatitis, Exfoliative; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphadenopathy; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Organoplatinum Compounds; Prednisolone; Prednisone; Sezary Syndrome; Vincristine | 2017 |
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisone; Radiotherapy, Adjuvant; Receptors, Antigen, T-Cell; Rituximab; Tomography, X-Ray Computed; Tongue | 2017 |
Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2008 |
[Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nausea; Prednisone; Remission Induction; Vincristine; Young Adult | 2008 |
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prospective Studies; Scotland; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2010 |
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Disease Progression; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Radiotherapy; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2013 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Humans; Induction Chemotherapy; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mucositis; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prognosis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous | 2002 |
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2003 |
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome; Vincristine | 2004 |
High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Panniculitis; Peripheral Blood Stem Cell Transplantation; Prednisone; Subcutaneous Tissue; Vincristine | 2005 |
Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Immunohistochemistry; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Skin Neoplasms | 2005 |
Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.
Topics: Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Proliferation; Cell Survival; Cycloheximide; Death-Associated Protein Kinases; Decitabine; Down-Regulation; Enzyme Activation; Etoposide; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Protein Synthesis Inhibitors | 2005 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine | 2006 |
[Prolonged remission after immunotherapy of a previously refractory peripheral T-cell non-Hodgkin lymphoma].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; L-Lactate Dehydrogenase; Lymphoma, T-Cell, Peripheral; Middle Aged; Neoplasm Staging; Prednisolone; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2006 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine | 2008 |
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosomes, Human, Pair 7; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Duplication; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Lymphoma, T-Cell, Peripheral; Prognosis; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 2000 |